Abivax S.A.(ABVX)

POST116.98-0.12-0.10%19:58 EST

117.10+0.30+0.26%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- Stock Track | Abivax S.A. Soars 5.08% Intraday After Truist Financial Maintains Buy Rating
  Stock Track · 01-13
  Stock Track | Abivax S.A. Soars 5.08% Intraday After Truist Financial Maintains Buy Rating
- Abivax SA Sponsored ADR (ABVX) Receives a Buy from Truist Financial
  TIPRANKS · 01-13
  Abivax SA Sponsored ADR (ABVX) Receives a Buy from Truist Financial
- U.S. Chess Champion is Bullish on these 3 Stocks – GOOG, ABVX, MP
  TIPRANKS · 01-13
  U.S. Chess Champion is Bullish on these 3 Stocks – GOOG, ABVX, MP
- Abivax higher after report of Eli Lilly takeover approach
  TIPRANKS · 01-12
  Abivax higher after report of Eli Lilly takeover approach
- France has had no request for investment approval in biotech Abivax - official
  Reuters · 01-12
  France has had no request for investment approval in biotech Abivax - official
- French Finance Ministry Has Received No Request Seeking Investment Approval in Pharma Company Abivax, Official Says
  THOMSON REUTERS · 01-12
  French Finance Ministry Has Received No Request Seeking Investment Approval in Pharma Company Abivax, Official Says
- Abivax Shares Soar 23% As Media Report Reignites M&A Chatter
  Reuters · 01-12
  Abivax Shares Soar 23% As Media Report Reignites M&A Chatter
- Sector Update: Health Care Stocks Lower Pre-Bell Monday
  MT Newswires Live · 01-12
  Sector Update: Health Care Stocks Lower Pre-Bell Monday
- Top Premarket Gainers
  MT Newswires Live · 01-12
  Top Premarket Gainers
- Why the market is now more sensitive to the latest battle between Jerome Powell and President Trump
  Dow Jones · 01-12
  Why the market is now more sensitive to the latest battle between Jerome Powell and President Trump
- Abivax Surges on Report Ely Lily is Preparing $17.5 Billion Bid
  Dow Jones · 01-12
  Abivax Surges on Report Ely Lily is Preparing $17.5 Billion Bid
- Stock Track | Abivax Soars 19.70% in Pre-Market Amid Eli Lilly Takeover Chatter
  Stock Track · 01-12
  Stock Track | Abivax Soars 19.70% in Pre-Market Amid Eli Lilly Takeover Chatter
- French Biotech Company Abivax Shares Soar 24% Amid Renewed Takeover Chatter
  Reuters · 01-12
  French Biotech Company Abivax Shares Soar 24% Amid Renewed Takeover Chatter
- Abivax price target raised to $145 from $101 at Morgan Stanley
  TIPRANKS · 01-09
  Abivax price target raised to $145 from $101 at Morgan Stanley
- Abivax price target raised to $150 from $120 at BTIG
  TIPRANKS · 01-08
  Abivax price target raised to $150 from $120 at BTIG
- Abivax Sa : Btig Raises Target Price to $150 From $120
  THOMSON REUTERS · 01-08
  Abivax Sa : Btig Raises Target Price to $150 From $120
- Abivax Banks on Market Potential for Drug Candidate Obefazimod
  MT Newswires Live · 01-08
  Abivax Banks on Market Potential for Drug Candidate Obefazimod
- European Equities Traded in US as ADRs Rise in Tuesday Trading
  MT Newswires Live · 01-07
  European Equities Traded in US as ADRs Rise in Tuesday Trading
- European Equities Traded in the US as American Depositary Receipts Rise Tuesday
  MT Newswires Live · 2025-12-31
  European Equities Traded in the US as American Depositary Receipts Rise Tuesday
- Guggenheim Bullish on Core Drug Obefazimod's Prospects, Assigns 'Buy' Rating to Abivax (ABVX.US)
  Stock News · 2025-12-29
  Guggenheim Bullish on Core Drug Obefazimod's Prospects, Assigns 'Buy' Rating to Abivax (ABVX.US)
Company Profile
Company Name
Abivax S.A.
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.abivax.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
- 01-08
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-10-28
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-07-24
  [Supp]Public Prospectus
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-07-23
  [Supp]Public Prospectus
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-03-24
  Employee Stock Ownership
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-03-24
  Annual Report
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-11-25
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-11-14
  Beneficial Ownership Change
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-04-19
  Beneficial Ownership Change
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2024-04-05
  Annual Report
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-02-14
  Beneficial Ownership Change
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 2023-11-23
  Beneficial Ownership Change
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-10-31
  Beneficial Ownership Change
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-10-31
  Beneficial Ownership Change
  Form SC 13D - General statement of acquisition of beneficial ownership
  Form SC 13D - General statement of acquisition of beneficial ownership
- 2023-10-20
  [Supp]Public Prospectus
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

1D
5D
Day
Week
Month

Loading ...

High

119.52

Open

117.23

Volume%

0.27

Low

116.03

116.80

T/O Rate

1.83%

To The Moon

Abivax S.A.(ABVX)

Company Profile

Most Discussed